1. A systematic review of adverse events in randomized trials assessing immune checkpoint inhibitors. Issue 3 (4th February 2019) Authors: Arnaud‐Coffin, Patrick; Maillet, Denis; Gan, Hui K.; Stelmes, Jean‐Jacques; You, Benoit; Dalle, Stephane; Péron, Julien Journal: International journal of cancer Issue: Volume 145:Issue 3(2019) Page Start: 639 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Actionable molecular alterations in advanced gynaecologic malignancies: updated results from the ProfiLER programme. (September 2019) Authors: Varnier, Romain; Le Saux, Olivia; Chabaud, Sylvie; Garin, Gwenaëlle; Sohier, Emilie; Wang, Qing; Paindavoine, Sandrine; Pérol, David; Baudet, Christian; Attignon, Valéry; Pissaloux, Daniel; Heudel, Pierre; You, Benoit; Leyronnas, Cécile; Collard, Olivier; Trédan, Olivier; Bonnin, Nathalie; Long, ... Journal: European journal of cancer Issue: Volume 118(2019) Page Start: 156 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Clinical efficacy of the optimal biological dose in early-phase trials of anti-cancer targeted therapies. (October 2019) Authors: Corbaux, Pauline; El-Madani, Mévidette; Tod, Michel; Péron, Julien; Maillet, Denis; Lopez, Jonathan; Freyer, Gilles; You, Benoit Journal: European journal of cancer Issue: Volume 120(2019) Page Start: 40 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Determination of Cetuximab in Plasma by Liquid Chromatography–High-Resolution Mass Spectrometry Orbitrap With a Stable Labeled 13C, 15N-Cetuximab Internal Standard. Issue 4 (August 2019) Authors: Millet, Aurélien; Lebert, Dorothée; Picard, Guillaume; You, Benoit; Ceruse, Philippe; Guitton, Jérôme Journal: Therapeutic drug monitoring Issue: Volume 41:Issue 4(2019:Aug.) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Validation of the Predictive Value of Modeled Human Chorionic Gonadotrophin Residual Production in Low-Risk Gestational Trophoblastic Neoplasia Patients Treated in NRG Oncology/Gynecologic Oncology Group–174 Phase III Trial. Issue 1 (1st January 2016) Authors: You, Benoit; Deng, Wei; Hénin, Emilie; Oza, Amit; Osborne, Raymond Journal: International journal of gynecological cancer Issue: Volume 26:Issue 1(2016) Page Start: 208 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. The role of the tumor primary chemosensitivity relative to the success of the medical-surgical management in patients with advanced ovarian carcinomas. (November 2021) Authors: You, Benoit; Freyer, Gilles; Gonzalez-Martin, Antonio; Lheureux, Stephanie; McNeish, Iain; Penson, Richard T.; Pignata, Sandro; Pujade-Lauraine, Eric Journal: Cancer treatment reviews Issue: Volume 100(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Multiparameter Phase I trials: a tool for model-based development of targeted agent combinations – example of EVESOR trial. (May 2015) Authors: El-Madani, Mevidette; Hénin, Emilie; Lefort, Thibaud; Tod, Michel; Freyer, Gilles; Cassier, Philippe; Valette, Pierre-Jean; Rodriguez-Lafrasse, Claire; Berger, Francoise; Guitton, Jérome; Lachuer, Joel; Slimane, Khemaies; Barrois, Catherine; You, Benoit Journal: Future oncology Issue: Volume 11:Number 10(2015) Page Start: 1511 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Multiparameter Phase I trials: a tool for model-based development of targeted agent combinations – example of EVESOR trial. (May 2015) Authors: El-Madani, Mevidette; Hénin, Emilie; Lefort, Thibaud; Tod, Michel; Freyer, Gilles; Cassier, Philippe; Valette, Pierre-Jean; Rodriguez-Lafrasse, Claire; Berger, Francoise; Guitton, Jérome; Lachuer, Joel; Slimane, Khemaies; Barrois, Catherine; You, Benoit Journal: Future oncology Issue: Volume 11:Number 10(2015) Page Start: 1511 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Multiparameter Phase I trials: a tool for model-based development of targeted agent combinations – example of EVESOR trial. (May 2015) Authors: El-Madani, Mevidette; Hénin, Emilie; Lefort, Thibaud; Tod, Michel; Freyer, Gilles; Cassier, Philippe; Valette, Pierre-Jean; Rodriguez-Lafrasse, Claire; Berger, Francoise; Guitton, Jérome; Lachuer, Joel; Slimane, Khemaies; Barrois, Catherine; You, Benoit Journal: Future oncology Issue: Volume 11:Number 10(2015) Page Start: 1511 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Cracking the homologous recombination deficiency code: how to identify responders to PARP inhibitors. (May 2022) Authors: Paulet, Lola; Trecourt, Alexis; Leary, Alexandra; Peron, Julien; Descotes, Françoise; Devouassoux-Shisheboran, Mojgan; Leroy, Karen; You, Benoit; Lopez, Jonathan Journal: European journal of cancer Issue: Volume 166(2022) Page Start: 87 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗